JFEYF yields 3.29% · JNJ yields 2.13%● Live data
📍 JFEYF pulled ahead of the other in Year 1
Combined, JFEYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JFEYF + JNJ for your $10,000?
JFE Systems, Inc. provides information systems integration, operation, and maintenance services in Japan. The company provides business systems integration services, including planning and consulting for information systems; design, development, and implementation of building information systems; operating, maintaining, and providing outsourcing services; and enhancing information systems. It also offers product-based solutions, such as building ERP/SCM/production planning systems, BI systems, cost management systems, procurement systems, electronic documentation systems, and quality information management and recipe management systems for the food industry, as well as various packaged software solutions. In addition, the company provides infrastructure/cloud computing solutions, which includes SaaS, PaaS, and IaaS; and system coordination and migration solutions. It serves finance, food products, logistics, automotive, and other manufacturing industries. JFE Systems, Inc. was formerly known as Kawasaki Steel Systems R&D Corporation and changed its name to JFE Systems, Inc. in 2004. The company was founded in 1983 and is headquartered in Tokyo, Japan. JFE Systems, Inc. is a subsidiary of JFE Steel Corporation.
Full JFEYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.